These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7743575)

  • 1. Acute quadriparesis in an asthmatic treated with atracurium.
    Tousignant CP; Bevan DR; Eisen AA; Fenwick JC; Tweedale MG
    Can J Anaesth; 1995 Mar; 42(3):224-7. PubMed ID: 7743575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle weakness in mechanically ventilated patients with severe asthma.
    Leatherman JW; Fluegel WL; David WS; Davies SF; Iber C
    Am J Respir Crit Care Med; 1996 May; 153(5):1686-90. PubMed ID: 8630621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged weakness after the withdrawal of atracurium.
    Manthous CA; Chatila W
    Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1441-3. PubMed ID: 7952572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged neuromuscular blockade in two critically ill patients treated with atracurium.
    Hoey LL; Joslin SM; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1995; 15(2):254-9. PubMed ID: 7624274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inconsistency with train-of-four monitoring in a critically ill paralyzed patient.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):540-5. PubMed ID: 7479211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose requirements of vecuronium, pancuronium, and atracurium during orthotopic liver transplantation.
    O'Kelly B; Jayais P; Veroli P; Lhuissier C; Ecoffey C
    Anesth Analg; 1991 Dec; 73(6):794-8. PubMed ID: 1683184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of integrated evoked EMG between the hypothenar and facial muscle groups following atracurium and vecuronium administration.
    Sharpe MD; Moote CA; Lam AM; Manninen PH
    Can J Anaesth; 1991 Apr; 38(3):318-23. PubMed ID: 1674676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal.
    Beattie WS; Buckley DN; Forrest JB
    Can J Anaesth; 1992 Nov; 39(9):925-31. PubMed ID: 1360337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination.
    Giostra E; Magistris MR; Pizzolato G; Cox J; Chevrolet JC
    Chest; 1994 Jul; 106(1):210-20. PubMed ID: 8020274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action.
    Brady MM; Mirakhur RK; Clarke RS
    Eur J Anaesthesiol; 1988 Jul; 5(4):243-9. PubMed ID: 2904367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine potentiates nondepolarizing neuromuscular relaxants in a primate.
    Tsai SK; Lee C
    Anesth Analg; 1989 Jan; 68(1):5-8. PubMed ID: 2562910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants.
    Fisher DM; Rosen JI
    Anesthesiology; 1986 Sep; 65(3):286-91. PubMed ID: 2875680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent paralysis after prolonged use of atracurium in the absence of corticosteroids.
    Rubio ER; Seelig CB
    South Med J; 1996 Jun; 89(6):624-6. PubMed ID: 8638206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute rhabdomyolysis in status asthmaticus].
    Eisenhuber E; Zauner C; Madl C; Kramer L; Ratheiser K
    Wien Klin Wochenschr; 1996; 108(16):521-4. PubMed ID: 8967096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to atracurium and mivacurium in a patient with Charcot-Marie-Tooth disease.
    Naguib M; Samarkandi AH
    Can J Anaesth; 1998 Jan; 45(1):56-9. PubMed ID: 9466029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuromuscular monitoring in a patient with hemiparesis. Resistance of the paralysed musculature to non-depolarising muscle relaxants].
    Müller R; Knüttgen D; Vorweg M; Doehn M
    Anaesthesist; 2002 Aug; 51(8):644-9. PubMed ID: 12391524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative evaluation of intubating doses of atracurium, d-tubocurarine, pancuronium and vecuronium in children.
    Montgomery CJ; Steward DJ
    Can J Anaesth; 1988 Jan; 35(1):36-40. PubMed ID: 2894902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.